Loading the company…
Loading the company…
No clearances or recalls under the mapped product codes.
All companies · Product and company coverage
In 2025, Microport Orthopedics reported engagement with 123 surgeons and other clinicians in the states MedaRep covers, worth $474K in consulting, speaking, meals and travel for its device products, the most in Tennessee ($156K to 4). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Tennessee ($156K, 4 engaged), Florida ($72K, 3 engaged), Michigan ($59K, 16 engaged), Illinois ($45K, 9 engaged), Colorado ($40K, 3 engaged).
In the last ten years FDA made 29 decisions for Microport Orthopedics (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 0 procedure families, the most in 2018 (5). The latest was on 2026-10-01.
| Ethylene Oxide Sterilization Supplier Change for MPO Hips |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Microport Orthopedics.